跳至主要内容
临床试验/NCT07280260
NCT07280260招募中4 期

Effects of Early Loading Protocol on the Survival of the Nobel N1 Implant System: A Pilot Randomized Controlled Trial

Louisiana State University Health Sciences Center in New Orleans2 个研究点 分布在 1 个国家目标入组 50 人开始时间: 2025年12月15日最近更新:

试验速览

阶段
4 期
状态
招募中
入组人数
50
试验地点
2
主要终点
Implant survival

研究概览

简要总结

The purpose of the study is to evaluate whether N1 dental implants are successful when a final crown is placed on them at 6 weeks from implant placement surgery.

详细描述

This study aims to evaluate the survival and stability of the Nobel N1 dental implant and its accompanying crown over a one-year period when the crown is placed either 6 or 12 weeks after implant placement. The Nobel N1 implant is an FDA-approved, newly designed implant featuring an innovative surgical placement protocol intended to minimize bone trauma, promote faster integration, and potentially allow for the placement of final crowns earlier-at 6 weeks instead of the traditional 4 to 5 months. This study will enroll adult participants who are missing a single tooth in the back of the mouth.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Males and females, age 18 or older
  • Can provide an Informed Consent in English.
  • Absence of a single posterior tooth in mandible or maxilla with presence of natural neighboring teeth (except for second molar which only requires presence of first molar)
  • Presence of antagonist teeth
  • Possibility and will for an immediate restoration.
  • Systemic health recorded as an American Society of Anesthesiologists (ASA) I or II

排除标准

  • · Unavailability to attend the follow-up visits.
  • A systemic contraindication for oral surgical procedures; ASA III or IV.
  • Pregnancy or nursing on screening or before the surgical procedure.
  • Diseases that could alter healing or bone metabolism (uncontrolled diabetes, diagnostic osteoporosis, etc.),
  • Taking medications that are altering healing or bone metabolism (bisphosphonates, long-time corticosteroids intake, RANK inhibitors, etc.)
  • Alcohol or drug abuse.
  • Current heavy smoking behavior (≥10 cigarettes/day).
  • Radiation therapy to the head or neck region.
  • Pathology in the implant planned sites that prevent implant placement.
  • Current diagnosis of Diabetes, which is uncontrolled (>7 HbA1C).
  • Need for sinus lift or vertical bone augmentation
  • Previously failed implant site

结局指标

主要结局

Implant survival

时间窗: 6 months, 1 year

Implant survival will be measured if it is not failed and still present at time points

Misch implant success criteria

时间窗: 6 months, 1 year

Implant success will be measured according to Misch et al.

次要结局

  • Marginal bone loss(6 months, 1 year)
  • Probing depth(6 months, 1 year)
  • Presence of sulcular suppuration on gentle probing(6 months, 1 year)
  • Presence of sulcular bleeding on gentle probing(6 months, 1 year)
  • Peri-implant Mucosal Tissue Index(Prosthetic delivery, 6 months, 1 year)
  • Patient satisfaction questionnaire(Prosthetic delivery, 6 months, 1 year)
  • Prosthetic complications(6 months, 1 year)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验

Clinical Performance of Nobel N1 System | 临床试验